Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
25 Results Found
White House issues executive order on drug pricing
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription drugs.
Commerce Department to investigate imports of pharmaceuticals, semiconductors
The Department of Commerce yesterday released notices announcing national security investigations on imports of
AHA files amicus brief in 4th Circuit in support of Maryland 340B contract pharmacy law
The AHA Feb.
Senate introduces bill requiring price disclosures on ads for prescription drugs
Sens. Dick Durbin, D-Ill., and Chuck Grassley, R-Iowa, Jan. 23 introduced the Drug-price Transparency for Consumers Act, legislation supported by the AHA that would require price disclosures on advertisements for prescription drugs. The bill would help ensure that consumers are able to make more informed decisions on prescription drugs.
HHS announces next 15 drugs selected for price negotiations
The Department of Health and Human Services Jan. 17 announced 15 Medicare Part D drugs selected for the latest round of price negotiations.
Report: Prices for top Medicare Part D drugs nearly doubled since entering the market
Prices for the top 25 brand-name Medicare Part D drugs have increased by an average of 98% since entering the market, according to a report released Jan. 9 by the AARP Public Policy Institute.
Research finds drug prices increased without adding new clinical benefits
The net prices of five drugs included in a new study from the Institute for Clinical and Ec
AHA responds to Medicare $2 Drug List Model request for information
The AHA supports a potential Medicare $2 Drug List Model, where people enrolled in a Part D plan would have access to certain prescription drugs for a low, fixed copayment no higher than $2 for a month’s supply per drug.
CMS releases RFI, sample list of prescription drugs that may be included under proposed Medicare $2 Drug List Model
The Centers for Medicare & Medicaid Services Oct. 9 released a request for information and a sample list of prescription drugs it intends to include under a proposed Medicare $2 Drug List Model.
Reminder: CMS hosting webinar Oct. 21 on price transparency machine-readable file 2025 requirements
The Centers for Medicare & Medicaid Services Oct. 21 will host a webinar on meeting its new hospital price transparency requirements becoming effective Jan. 1.